• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病门诊中6例患有家族性部分脂肪营养不良的日本糖尿病女性患者的临床特征、脂肪营养不良表型及基因分析

Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic.

作者信息

Iwanishi Masanori, Ito-Kobayashi Jun, Washiyama Miki, Kusakabe Toru, Ebihara Ken

机构信息

Department of Diabetes and Endocrinology, Kusatsu General Hospital, Japan.

Department of Endocrinology, Metabolism and Hypertension, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

出版信息

Intern Med. 2018 Aug 15;57(16):2301-2313. doi: 10.2169/internalmedicine.0225-17. Epub 2018 Mar 30.

DOI:10.2169/internalmedicine.0225-17
PMID:29607946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6148158/
Abstract

Objective Our aim was to examine the clinical characteristics and phenotype of lipodystrophy of six diabetic Japanese women with partial lipodystrophy (PL) who received a genetic analysis at a diabetic outpatient clinic. Methods We screened for PL using dual energy X-ray absorptiometry (DEXA) and magnetic resonance imaging (MRI) among patients who had a reduced peripheral skinfold thickness at the diabetic outpatient clinic of Kusatsu General Hospital between August 2003 and August 2013. We performed a mutation analysis of candidate genes, including LMNA and PPARG, in two patients with PL and whole-exome sequencing in four patients with PL. Results We identified 15 patients with PL and performed a genetic analysis in 6 of them. They had no mutations in candidate genes known to be associated with familial partial lipodystrophy (FPLD). They all had near-complete loss of subcutaneous fat, particularly in the antero-lateral and posterior thigh region and the calf region. As almost all patients were characterized by fat loss in the lower limbs with abdominal fat accumulation, a high rate of positivity for a family history, diabetes, and an unknown genetic cause, we suspected they might have FPLD1. Some patients have shown relatively severe insulin resistance, while others have shown insulin deficiency. Four and one had severe atherosclerosis and liver cirrhosis, probably due to nonalcoholic steatohepatitis, respectively. Conclusion Almost all patients with PL identified in a diabetic outpatient clinic had subcutaneous fat loss in the lower limbs with excess truncal fat and might have had FPLD1.

摘要

目的 我们的目的是研究6名日本糖尿病女性患者的临床特征和脂肪营养不良的表型,这些患者患有部分脂肪营养不良(PL),并在糖尿病门诊接受了基因分析。方法 我们在2003年8月至2013年8月期间,于草津市立综合医院糖尿病门诊对周围皮肤褶厚度降低的患者中,使用双能X线吸收法(DEXA)和磁共振成像(MRI)筛查PL。我们对2例PL患者进行了候选基因(包括LMNA和PPARG)的突变分析,对4例PL患者进行了全外显子测序。结果 我们确定了15例PL患者,并对其中6例进行了基因分析。他们在已知与家族性部分脂肪营养不良(FPLD)相关的候选基因中没有突变。他们都几乎完全丧失了皮下脂肪,尤其是大腿前外侧和后侧区域以及小腿区域。由于几乎所有患者的特征都是下肢脂肪减少伴腹部脂肪堆积、家族史阳性率高、糖尿病以及遗传原因不明,我们怀疑他们可能患有FPLD1。一些患者表现出相对严重的胰岛素抵抗,而另一些患者表现出胰岛素缺乏。分别有4例和1例患有严重的动脉粥样硬化和肝硬化,可能分别是由于非酒精性脂肪性肝炎所致。结论 在糖尿病门诊确定的几乎所有PL患者都有下肢皮下脂肪减少伴躯干脂肪过多的情况,可能患有FPLD1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/1ea89e433d9d/1349-7235-57-2301-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/821995c8e8e7/1349-7235-57-2301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/9e42351d9f97/1349-7235-57-2301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/00278cb4af74/1349-7235-57-2301-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/58ee5e61345e/1349-7235-57-2301-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/1ea89e433d9d/1349-7235-57-2301-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/821995c8e8e7/1349-7235-57-2301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/9e42351d9f97/1349-7235-57-2301-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/00278cb4af74/1349-7235-57-2301-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/58ee5e61345e/1349-7235-57-2301-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/6148158/1ea89e433d9d/1349-7235-57-2301-g005.jpg

相似文献

1
Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic.糖尿病门诊中6例患有家族性部分脂肪营养不良的日本糖尿病女性患者的临床特征、脂肪营养不良表型及基因分析
Intern Med. 2018 Aug 15;57(16):2301-2313. doi: 10.2169/internalmedicine.0225-17. Epub 2018 Mar 30.
2
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.家族性部分性脂肪营养不良患者的临床表现、代谢异常及终末器官并发症
Metabolism. 2017 Jul;72:109-119. doi: 10.1016/j.metabol.2017.04.010. Epub 2017 Apr 27.
3
Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.与新型过氧化物酶体增殖物激活受体-γ(PPARG)突变H449L相关的家族性部分脂肪营养不良:该突变患者与经典密码子482型核纤层蛋白A/C(LMNA)突变患者的比较
Diabet Med. 2016 Oct;33(10):1445-50. doi: 10.1111/dme.13061. Epub 2016 Feb 5.
4
Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.人体测量学指标对 Dunnigan 型家族性部分性脂肪营养不良的诊断价值。
J Clin Endocrinol Metab. 2020 Jul 1;105(7):2132-41. doi: 10.1210/clinem/dgaa137.
5
Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation.吡格列酮对一名因过氧化物酶体增殖物激活受体γ基因突变导致家族性部分脂肪营养不良的日本患者的临床特征及疗效
Endocr J. 2023 Jan 30;70(1):69-76. doi: 10.1507/endocrj.EJ22-0140. Epub 2022 Sep 29.
6
Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C).非肥胖型糖尿病患者存在明显胰岛素抵抗的特征,确定了一种新型家族性部分脂肪营养不良相关的 PPARγ 突变(Y151C)。
Diabetologia. 2011 Jul;54(7):1639-44. doi: 10.1007/s00125-011-2142-4. Epub 2011 Apr 9.
7
Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family.波兰一个家族中杂合子 LMNA 突变 1445G>A(Arg482Gln)与家族性部分脂肪营养不良相关。
Neurol Neurochir Pol. 2010 May-Jun;44(3):291-6. doi: 10.1016/s0028-3843(14)60044-x.
8
Clinical and imaging features of women with polygenic partial lipodystrophy: a case series.多基因部分性脂肪营养不良女性的临床和影像学特征:病例系列。
Nutr Diabetes. 2024 Feb 6;14(1):3. doi: 10.1038/s41387-024-00260-y.
9
Premature atherosclerosis in a Japanese diabetic patient with atypical familial partial lipodystrophy and hypertriglyceridemia.一名患有非典型家族性部分脂肪营养不良和高甘油三酯血症的日本糖尿病患者出现过早动脉粥样硬化。
Intern Med. 2012;51(18):2573-9. doi: 10.2169/internalmedicine.51.7461. Epub 2012 Sep 15.
10
Köbberling type of familial partial lipodystrophy: an underrecognized syndrome.科贝林型家族性部分脂肪营养不良:一种未被充分认识的综合征。
Diabetes Care. 2003 Jun;26(6):1819-24. doi: 10.2337/diacare.26.6.1819.

引用本文的文献

1
Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1.观察到 Mysterin 基因的 p.R4810K 多态性,该基因是家族性部分脂肪营养不良 1 型的易感性基因,在两名日本女性糖尿病患者中发现。
Intern Med. 2020;59(20):2529-2537. doi: 10.2169/internalmedicine.4042-19. Epub 2020 Oct 15.
2
Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.脂肪营养不良的表型和遗传学特征:病理生理学、代谢异常和合并症。
Curr Diab Rep. 2018 Nov 8;18(12):143. doi: 10.1007/s11892-018-1099-9.

本文引用的文献

1
Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report.钠-葡萄糖协同转运蛋白2抑制剂改善脂肪营养不良并发症:一例报告
Ann Intern Med. 2017 Mar 21;166(6):450-451. doi: 10.7326/L16-0372.
2
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis.噻唑烷二酮类药物与非酒精性脂肪性肝炎中的晚期肝纤维化:一项荟萃分析。
JAMA Intern Med. 2017 May 1;177(5):633-640. doi: 10.1001/jamainternmed.2016.9607.
3
Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reports.
胰高血糖素样肽-1类似物——脂肪营养不良综合征严重胰岛素抵抗的有效治疗选择:两例病例报告
J Med Case Rep. 2017 Jan 13;11(1):12. doi: 10.1186/s13256-016-1175-1.
4
Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.整合基因组分析表明,外周脂肪储存能力有限与人类胰岛素抵抗的发病机制有关。
Nat Genet. 2017 Jan;49(1):17-26. doi: 10.1038/ng.3714. Epub 2016 Nov 14.
5
Lipodystrophy Syndromes.脂肪营养不良综合征。
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. doi: 10.1016/j.ecl.2016.06.012. Epub 2016 Oct 6.
6
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.脂肪营养不良综合征的诊断与管理:多学会实践指南
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6.
7
Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.1型家族性部分脂肪营养不良:认识科贝林综合征。
Endocrine. 2016 Nov;54(2):411-421. doi: 10.1007/s12020-016-1002-x. Epub 2016 Jul 30.
8
Partial lipodystrophy of the limbs in a diabetes clinic setting.糖尿病门诊环境下的肢体局部脂肪营养不良
Prim Care Diabetes. 2016 Aug;10(4):293-9. doi: 10.1016/j.pcd.2015.12.006. Epub 2016 Jan 8.
9
PCSK5 mutation in a patient with the VACTERL association.一名患有VACTERL综合征患者的PCSK5基因突变
BMC Res Notes. 2015 Jun 9;8:228. doi: 10.1186/s13104-015-1166-0.
10
A lifetime on the hips: programming lower-body fat to protect against metabolic disease.臀部脂肪的一生:调控下半身脂肪以预防代谢性疾病。
Diabetes. 2014 Nov;63(11):3575-7. doi: 10.2337/db14-1085.